In Deusa Cast #54, Marco Fiaschetti advocates for treatment customization and the inclusion of the compounding model in the revision of RDC 327

Bill under review in Delaware may allow the use of medical cannabis in hospitals by terminal patients, with specific safety and storage rules

Cannabis sales in Michigan hit a record high in 2025, but a drop in prices reduces the sector's revenue, according to state market data

Patient follow-up for up to two years

Episode of Deusa Cast brings together experts to discuss therapeutic cannabis, integrative health, and the potential of hemp in medicine, dentistry, and sustainable fashion.

CFO supports dentists among authorized professionals to prescribe safely and with quality

Proposal put forth by Republican senators aims to block the use of federal resources to reschedule cannabis in the United States

Debate on the Sechat Portal podcast compares Rivotril and medical cannabis, highlighting effectiveness, safety, side effects, and differences between acute use and long-term treatment

The experiment aims to expose plants to microgravity for nine months following a capsule recovery failure in 2025

Process could determine whether the genetics will be classified as a genetically modified organism or treated as a conventional plant in Brazil

Cannabis prices in Oregon (USA) have reached historically low levels, while official data indicates that consumer demand remains stable in the state

Financial contributions from major companies in the sector occurred months before the president's executive measure, aiming for a change in federal legislation

Financial consolidation, cultivation regulation, and strengthening of events mark the sector's prospects for the next year

Bill on medicinal cannabis in Germany enters a decisive phase in Parliament and receives warnings from experts about regulatory and implementation challenges

A scientific review highlights the lack of robust evidence on medical cannabis and reinforces the need for more rigorous and balanced research in the field

Agency presents new report without a defined timeline, while experts warn that a change to Schedule III would have profound impacts on research and taxation, but not federal legalization

In a study, a Dutch university reveals how cannabis developed the ability to produce THC, CBD, and CBC through the evolution of ancestral enzymes

Global Index falls by 4.2% during the year, but American operators diverge from the global scenario and show significant growth

Expert warns that the change in law alone does not guarantee exponential growth without banking reforms and institutional access

IM Cannabis' decision comes after an executive order by Donald Trump that accelerates the reclassification of marijuana in the North American territory